Wenju Chang
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 17
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 22
- Colorectal Cancer Surgical Treatments 15
- Cancer Immunotherapy and Biomarkers 7
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
-
- Gastric Cancer Management and Outcomes 12
- Lung Cancer Treatments and Mutations 7
-
- Colorectal and Anal Carcinomas 12
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Management and Research (5 papers)Annals of Oncology (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Wenju Chang
76 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 105
- Hepatology 201
- Oncology 535
- Cancer Research 249
- Immunology 210
- Pulmonary and Respiratory Medicine 292
Countries citing papers authored by Wenju Chang
This map shows the geographic impact of Wenju Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenju Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenju Chang more than expected).
Fields of papers citing papers by Wenju Chang
This network shows the impact of papers produced by Wenju Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenju Chang. The network helps show where Wenju Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenju Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 40 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 44 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 60 | |
| 12 | 2019 | 104 | |
| 13 | 2019 | 2 | |
| 14 | 2018 | 87 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 25 | |
| 18 | 2015 | 19 | |
| 19 | 2015 | 32 | |
| 20 | 2012 | 29 |
About Wenju Chang
Wenju Chang is a scholar working on Hepatology, Oncology and Cancer Research, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (12 papers), Gastric Cancer Management and Outcomes (12 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Hepatology (201 citations), Oncology (535 citations) and Cancer Research (249 citations). Wenju Chang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ye Wei, Dexiang Zhu, Guodong He, Meiling Ji, Jianmin Xu, Xinyu Qin, Li Ren, Qingyang Feng, Wentao Tang and Lujun Song. Their work appears in journals such as Journal of Clinical Oncology, Cancer Management and Research, Annals of Oncology, International Journal of Surgery and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.